BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23776529)

  • 1. Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats.
    Hansen CF; Bueter M; Theis N; Lutz T; Paulsen S; Dalbøge LS; Vrang N; Jelsing J
    PLoS One; 2013; 8(6):e65696. PubMed ID: 23776529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes.
    Rhee NA; Wahlgren CD; Pedersen J; Mortensen B; Langholz E; Wandall EP; Friis SU; Vilmann P; Paulsen SJ; Kristiansen VB; Jelsing J; Dalbøge LS; Poulsen SS; Holst JJ; Vilsbøll T; Knop FK
    Diabetologia; 2015 Oct; 58(10):2254-8. PubMed ID: 26186884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.
    Mumphrey MB; Patterson LM; Zheng H; Berthoud HR
    Neurogastroenterol Motil; 2013 Jan; 25(1):e70-9. PubMed ID: 23095091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide Tyrosine-Tyrosine Triggers GLP-2-Mediated Intestinal Hypertrophy After Roux-en-Y Gastric Bypass.
    Pérez-Arana GM; Díaz-Gómez A; Camacho-Ramírez A; Ribelles-García A; Almorza-Gomar D; Gracia-Romero M; Prada-Oliveira JA
    Obes Surg; 2022 Dec; 32(12):4023-4032. PubMed ID: 36301409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation.
    le Roux CW; Borg C; Wallis K; Vincent RP; Bueter M; Goodlad R; Ghatei MA; Patel A; Bloom SR; Aylwin SJ
    Ann Surg; 2010 Jul; 252(1):50-6. PubMed ID: 20562614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Leading Role of Peptide Tyrosine Tyrosine in Glycemic Control After Roux-en-Y Gastric Bypass in Rats.
    Camacho-Ramírez A; Prada-Oliveira JA; Ribelles-García A; Almorza-Gomar D; Pérez-Arana GM
    Obes Surg; 2020 Feb; 30(2):697-706. PubMed ID: 31701411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats.
    Zhang C; Rigbolt K; Petersen SL; Biehl Rudkjær LC; Schwahn U; Fernandez-Cachon ML; Bossart M; Falkenhahn M; Theis S; Hübschle T; Schmidt T; Just Larsen P; Vrang N; Jelsing J
    Peptides; 2019 Aug; 118():170100. PubMed ID: 31212005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 and PYY
    Dischinger U; Corteville C; Otto C; Fassnacht M; Seyfried F; Hankir MK
    Surg Obes Relat Dis; 2019 Sep; 15(9):1483-1492. PubMed ID: 31548004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.
    Suzuki S; Ramos EJ; Goncalves CG; Chen C; Meguid MM
    Surgery; 2005 Aug; 138(2):283-90. PubMed ID: 16153438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PYY-Dependent Restoration of Impaired Insulin and Glucagon Secretion in Type 2 Diabetes following Roux-En-Y Gastric Bypass Surgery.
    Ramracheya RD; McCulloch LJ; Clark A; Wiggins D; Johannessen H; Olsen MK; Cai X; Zhao CM; Chen D; Rorsman P
    Cell Rep; 2016 May; 15(5):944-950. PubMed ID: 27117413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of enteroendocrine cell glucagon-like peptide (GLP)-1 release by fat-induced small intestinal ketogenesis: a mechanism targeted by Roux-en-Y gastric bypass surgery but not by preoperative very-low-calorie diet.
    Wallenius V; Elias E; Elebring E; Haisma B; Casselbrant A; Larraufie P; Spak E; Reimann F; le Roux CW; Docherty NG; Gribble FM; Fändriks L
    Gut; 2020 Aug; 69(8):1423-1431. PubMed ID: 31753852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RYGB surgery has modest effects on intestinal morphology and gut hormone populations in the bypassed biliopancreatic limb but causes reciprocal changes in GLP-2 and PYY in the alimentary limb.
    Sridhar A; Khan D; Elliott JA; Naughton V; Flatt PR; Irwin N; Moffett CR
    PLoS One; 2023; 18(5):e0286062. PubMed ID: 37228045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
    Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
    Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
    Grunddal KV; Ratner CF; Svendsen B; Sommer F; Engelstoft MS; Madsen AN; Pedersen J; Nøhr MK; Egerod KL; Nawrocki AR; Kowalski T; Howard AD; Poulsen SS; Offermanns S; Bäckhed F; Holst JJ; Holst B; Schwartz TW
    Endocrinology; 2016 Jan; 157(1):176-94. PubMed ID: 26469136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats.
    Chelikani PK; Shah IH; Taqi E; Sigalet DL; Koopmans HH
    Obes Surg; 2010 Sep; 20(9):1281-8. PubMed ID: 20386999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
    Osto E; Doytcheva P; Corteville C; Bueter M; Dörig C; Stivala S; Buhmann H; Colin S; Rohrer L; Hasballa R; Tailleux A; Wolfrum C; Tona F; Manz J; Vetter D; Spliethoff K; Vanhoutte PM; Landmesser U; Pattou F; Staels B; Matter CM; Lutz TA; Lüscher TF
    Circulation; 2015 Mar; 131(10):871-81. PubMed ID: 25673670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal sensing and handling of dietary lipids in gastric bypass-operated patients and matched controls.
    Martinussen C; Dirksen C; Bojsen-Møller KN; Svane MS; Carlsson ER; Hartmann B; Clausen TR; Veedfald S; Kristiansen VB; Rehfeld JF; Hansen HS; Holst JJ; Madsbad S
    Am J Clin Nutr; 2020 Jan; 111(1):28-41. PubMed ID: 31742316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.